Publications by authors named "Moawia M A Al-Tabakha"
Pharmaceutics
September 2024
Article Synopsis
- The pharmacy profession is evolving due to advancements in patient care, with the introduction of Spritam, the first 3D-printed drug, sparking interest in using 3D printing techniques like FDM for drug production.
- This review explores FDM 3D printing in medication development, covering its operations, benefits like personalized medicine, and challenges, such as drug stability and high temperature issues.
- An analysis of 14 studies indicates a rising global interest in FDM 3D-printed polypills, particularly from the UK, but highlights the need for addressing limitations like high printing temperatures and lack of standard production guidelines for broader application.
